Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW July 2000

Volume 9
Issue Number 7
July 2000
ISSN 10593802

Abarelix Eliminates Flare

A comparison of abarelix and leuprolide in prostate cancer patients shows the former to achieve medical castration without a testosterone flare. Abarelix also suppresses FSH (Follicle Stimulating Hormone).
Go to Previous Page

Source & Additional Reading

Thirty-Sixth Annual Meeting of the American Society of Clinical Oncology in New Orleans.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW July 2000

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW July 2000